MktsMarkets

ABVC BioPharma, Inc.
NASDAQ: ABVCKey statistics
ABVC News
Stories mentioning ABVC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 796.00 | 3.00 | 389.00 | 117.00 | ||||
| Cost of Goods Sold | 1.00 | 0.00 | 0.00 | |||||
| Gross Profit | 0.00 | (796.00) | 796.00 | 0.00 | 0.00 | 2.00 | 389.00 | 117.00 |
| Operating Expenses | ||||||||
| Research & Development | 33.00 | 29.00 | 30.00 | 33.00 | 29.00 | 32.00 | 38.00 | 40.00 |
| Sales General & Admin | 752.00 | 784.00 | 798.00 | 690.00 | 615.00 | 311.00 | 558.00 | 654.00 |
| Total Operating Expenses | 1,572 | 2,199 | 1,964 | 2,295 | 693.00 | 707.00 | 691.00 | 977.00 |
| Operating Income (Loss) | (1,572) | (2,995) | (1,168) | (2,295) | (693.00) | (705.00) | (302.00) | (860.00) |
| Interest Income | 4.00 | 82.00 | 47.00 | 19.00 | 19.00 | 12.00 | 44.00 | 27.00 |
| Interest Expense | ||||||||
| Other Expense | (1.00) | (11.00) | 2.00 | (7.00) | 2.00 | 89.00 | (7.00) | 33.00 |
| Pretax Income | (1,690) | (3,813) | (1,287) | (2,309) | (944.00) | (797.00) | (487.00) | (1,158) |
| Tax Provision | 1.00 | 24.00 | 0.00 | (111.00) | ||||
| Net Income (Loss) | (1,560) | (3,563) | (1,247) | (2,257) | (842.00) | (732.00) | (395.00) | (942.00) |
| Earnings Per Share (Basic) | (0.06) | (0.18) | (0.05) | (0.13) | (0.06) | (0.06) | (0.03) | (0.08) |
| Earnings Per Share (Diluted) | (0.06) | (0.18) | (0.05) | (0.13) | (0.06) | (0.06) | (0.03) | (0.08) |
| Weighted Average Shares Outstanding (Basic) | 25,449 | 20,109 | 23,257 | 17,387 | 14,968 | 11,674 | 12,405 | 11,321 |
| Weighted Average Shares Outstanding (Diluted) | 25,449 | 20,109 | 23,257 | 17,387 | 14,968 | 11,674 | 12,405 | 11,321 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ABVC
ABVC BioPharma, Inc. (NASDAQ: ABVC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABVC. It last traded at $0.9100 (Nov 13, 2026, 4:00 PM ET), down 5.6% on the day. That gives ABVC BioPharma a market capitalisation of $24.5M.
Over the past 52 weeks ABVC has traded between $0.7100 and $3.06.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$1.6M | — |
| Dec 31, 2025 | — | -$3.6M | — |
| Sep 30, 2025 | $796.0K | -$1.2M | -156.7% |
| Jun 30, 2025 | — | -$2.3M | — |
From ABVC BioPharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…